Showing results (31-40 of 65) with videos related to
Sort By:
Pageof 7
Neuro-Oncology Advances|May 4, 2022
Corrigendum to: A phase II study of laser interstitial thermal therapy combined with doxorubicin in patients with recurrent glioblastomaOmar H Butt, Alice Y Zhou, Jiayi Huang, et al.Neuro-Oncology Advances|July 24, 2025
Phase I study of NT-I7, a long-acting interleukin-7, in severe treatment-related lymphopenia following standard radiation and temozolomide for high-grade gliomaJian L Campian, Stuart A Grossman, Angela Shaulov Kask, et al.Genes & Development|April 18, 2012
Emerging insights into the molecular and cellular basis of glioblastomaGavin P Dunn, Mikael L Rinne, Jill Wykosky, et al.Cell Reports. Medicine|December 17, 2025
Intracranial injection of genetically modified, mosquito non-transmissible Zika virus: Safety in primates and ramifications for brain tumor therapyAlec J Hirsch, Amanda de Andrade Costa, Cody German, et al.Neuro-Oncology Practice|May 23, 2022
A randomized feasibility study evaluating temozolomide circadian medicine in patients with gliomaAnna R Damato, Ruth G N Katumba, Jingqin Luo, et al.Cancer Cell|May 19, 2010
PLAGL2 regulates Wnt signaling to impede differentiation in neural stem cells and gliomasHongwu Zheng, Haoqiang Ying, Ruprecht Wiedemeyer, et al.International Journal of Radiation Oncology, Biology, Physics|May 20, 2024
A Phase 1/2 Study of Disulfiram and Copper With Concurrent Radiation Therapy and Temozolomide for Patients With Newly Diagnosed GlioblastomaJiayi Huang, Jian L Campian, Todd A DeWees, et al.JCI Insight|September 22, 2020
Schwannoma development is mediated by Hippo pathway dysregulation and modified by RAS/MAPK signalingZhiguo Chen, Stephen Li, Juan Mo, et al.Nature Communications|February 26, 2026
Laser interstitial thermal therapy and adjuvant pembrolizumab in recurrent high-grade astrocytoma: a Phase 1/randomized Phase 2b trialJian L Campian, Son B Le, Ashley Ghiaseddin, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 25, 2026
NT-I7, a long-acting interleukin-7, increases lymphocyte counts and induces CD8+ T cell clonotype expansion in patients with newly diagnosed high-grade gliomasOmar H Butt, Kartik Singhal, Jingqin Luo, et al.Pageof 7